GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (AMEX:ASXC) » Definitions » E10

Asensus Surgical (Asensus Surgical) E10 : $-7.03 (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Asensus Surgical E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Asensus Surgical's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.080. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-7.03 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 39.60% per year. During the past 5 years, the average E10 Growth Rate was 23.10% per year. During the past 10 years, the average E10 Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Asensus Surgical was 55.40% per year. The lowest was -69.40% per year. And the median was 1.50% per year.

As of today (2024-06-07), Asensus Surgical's current stock price is $0.3311. Asensus Surgical's E10 for the quarter that ended in Mar. 2024 was $-7.03. Asensus Surgical's Shiller PE Ratio of today is .


Asensus Surgical E10 Historical Data

The historical data trend for Asensus Surgical's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical E10 Chart

Asensus Surgical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.21 -32.39 -33.01 -22.86 -7.15

Asensus Surgical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.79 -9.23 -7.51 -7.15 -7.03

Competitive Comparison of Asensus Surgical's E10

For the Medical Devices subindustry, Asensus Surgical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asensus Surgical's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Asensus Surgical's Shiller PE Ratio falls into.



Asensus Surgical E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Asensus Surgical's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.08/131.7762*131.7762
=-0.080

Current CPI (Mar. 2024) = 131.7762.

Asensus Surgical Quarterly Data

per share eps CPI Adj_EPS
201406 -2.340 100.560 -3.066
201409 -2.340 100.428 -3.070
201412 -1.690 99.070 -2.248
201503 -2.080 99.621 -2.751
201506 -1.820 100.684 -2.382
201509 -2.080 100.392 -2.730
201512 -1.690 99.792 -2.232
201603 -1.560 100.470 -2.046
201606 -9.100 101.688 -11.793
201609 -1.430 101.861 -1.850
201612 -1.560 101.863 -2.018
201703 -1.690 102.862 -2.165
201706 -1.430 103.349 -1.823
201709 -3.380 104.136 -4.277
201712 -5.980 104.011 -7.576
201803 -0.057 105.290 -0.071
201806 -2.210 106.317 -2.739
201809 -1.300 106.507 -1.608
201812 -0.390 105.998 -0.485
201903 -1.350 107.251 -1.659
201906 -1.350 108.070 -1.646
201909 -5.550 108.329 -6.751
201912 -0.690 108.420 -0.839
202003 -0.590 108.902 -0.714
202006 -0.270 108.767 -0.327
202009 -0.150 109.815 -0.180
202012 -0.130 109.897 -0.156
202103 -0.080 111.754 -0.094
202106 -0.060 114.631 -0.069
202109 -0.070 115.734 -0.080
202112 -0.070 117.630 -0.078
202203 -0.080 121.301 -0.087
202206 -0.080 125.017 -0.084
202209 -0.080 125.227 -0.084
202212 -0.080 125.222 -0.084
202303 -0.090 127.348 -0.093
202306 -0.090 128.729 -0.092
202309 -0.070 129.860 -0.071
202312 -0.060 129.419 -0.061
202403 -0.080 131.776 -0.080

Add all the adjusted EPS together and divide 10 will get our e10.


Asensus Surgical  (AMEX:ASXC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Asensus Surgical E10 Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Asensus Surgical (Asensus Surgical) Business Description

Traded in Other Exchanges
Address
1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.
Executives
Starling William N Jr director 2300 BUCKSKIN ROAD, POCATELLO ID 83201
Andrea Biffi director C/O SOFAR SPA, VIA FIRENZE 40, TREZZANO ROSA (MI) L6 20060
Elizabeth Kwo director C/O FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON MA 01803
David Bruce Milne director ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108
Kevin J Hobert director 343 STATE STREET, ROCHESTER NY 14650
Fernando Anthony C. J. officer: Chief Technology Officer 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Rampertab Shameze officer: EVP, Chief Financial Officer C/O ZOMEDICA PHARMACEUTICALS CORP., 3928 VARSITY DRIVE, ANN ARBOR MI 48108
Brett Farabaugh officer: Interim CFO 108 T.W. ALEXANDER DRIVE, RESEARCH TRIANGLE PARK NC 27709
Joseph P Slattery officer: EVP and CFO C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Eric A Smith officer: Chief Commercial Officer 7 CALEB CIRCLE, SAN ANTONIO TX 78258
Todd Pope director, officer: President and CEO C/O TRANSENTERIX, 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27713
Willam N Kelley director MERCK & CO., INC., ONE MERCK DRIVE, WHITEHOUSE STATION X1 08889
Pfenniger Richard C Jr director 4400 BISCAYNE BLVD., MIAMI FL 33137
Sofar, S.p.a 10 percent owner VIA FIRENZE 40, TREZZANO ROSA L6 20060
Andrew N Schiff director, 10 percent owner PLANET ZANETT INC, 135 E 57TH ST, NEW YORK NY 10022

Asensus Surgical (Asensus Surgical) Headlines

From GuruFocus